Background: The Btk (Bruton's tyrosine kinase) gene has been shown to be mutated in the human immunodeficiency disease, XLA (X-linked agammaglobulinemia). Btk is a member of the Tec family of cytosolic
protein tyrosine kinases with distinct functional domains PH, TH, SH3, SH2, and kinase. Mutations have been observed in each of the Btk subdomains in XLA. We have analyzed the Btk gene in six XLA patients from five unrelated families. Materials and Methods: DNA was prepared from the patients' peripheral blood. The Btk exons including the junctional sequences were analyzed by single-strand conformation polymorphism (SSCP) followed by direct nucleotide sequencing after PCR-amplification. For structural analysis, the missense mutations were introduced into three-dimensional models of the PH and kinase domains of Btk and the outcome was predicted based on the knowledge of the protein function. Results: Five novel mutations and two novel polymorphisms, all of which resulted from single-base alterations, were identified. Three of the five mutations were in the PH domain and two were in the kinase domain of Btk. Three of these mutations were of the missense type, two of which altered the same codon in the PH domain; the third one was located in the kinase domain. The fourth mutation was a point deletion in the PH domain causing a frameshift followed by premature termination. The fifth mutation was a splice donor-site mutation within the kinase domain which could result in an exon skipping. In four of the five instances, mothers of the patients were shown to be obligate carriers. In one instance, a sibling sister was identified as a heterozygote establishing her as a carrier. Conclusions: Functional consequences of the mutations causing frameshifts and altered splicing can be inferred directly. Functional consequences of the missense mutations were interpreted by 3-dimensional structural modeling of Btk domains. It is proposed that the two PH domain mutations will interfere with membrane localization while the kinase domain mutation will interfere with the enzymatic function of Btk. This study provides further insight into the role of Btk in XLA.
INTRODUCTION
X-linked agammaglobulinemia (XLA) is the first immunodeficiency disorder to be described in humans (1) 
Structural Analysis
The structural consequences of the missense mutations were predicted based on the three-dimensional models of the PH and kinase domains of Btk described previously (14, 15, 18) . The models have been built based on X-ray crystal structures of related proteins, dynamin PH domain (19, 20) and cyclic AMP-dependent protein kinase (21) . The missense mutations were introduced into the models and the outcome of the amino acid substitutions was predicted based on the knowledge about protein structure and function.
RESULTS
The six XLA patients (P20, P14, P3, P2 (Fig. 2) would result in the amino acid substitution Y40N. The mother and a sister of P20 were found to be heterozygous for T/A at nucleotide 250 ( Fig. 2) , indicating that they both were carriers and confirming the mutation in the proband. P14 had an A-to-G transition at nucleotide 251 ( Fig. 2) The second mutation in the kinase domain was revealed by the two siblings, Pl1 and P12. The G-to-T transversion at the first nucleotide of intron 18 at position 2040 (+ 1) (data not shown) would result in the loss of an Mnll restriction site and gain of an MseI restriction site. The mother of P11 and P12, as can be expected, was a carrier (data not shown). This splice donor-site mutation is expected to cause an aberrant splicing that would result in skipping of exon 18 followed by a frameshift (Fig. 3, ref. 22 ). This would lead to premature termination after the insertion of three missense amino acids following residue 583. The resulting truncated protein would lack several amino acids from the C-terminus of Btk and is likely to be functionally inactive as deletion of a few terminal residues can lead to XLA (16) . This mutation could also lead to novel splicing and unusual transcripts (23) .
DNA Polymorphisms During the course of this work we encountered three C/T silent polymorphisms that were initially detected as SSCPs and subsequently confirmed by DNA sequencing ( Table 2 ). The first of (Table 2) can be identified directly by restriction digestion, following PCR-amplification or followed by Southern blot hybridization, and are extremely useful for linkage mapping in the absence of a known mutation (26) . Finally, an exonic polymorphism (Table 2) can be conveniently utilized as an EST to track RNA transcripts and to monitor X chromosome inactivation in different cell/tissue types in a heterozygote (8) .
DISCUSSION
Although over 200 unique mutations in XLA patients have been listed in the BTKbase (13), the five mutations along with two of the polymorphisms reported here are novel. The functional consequence of the mutation in P3 or P1 l/P1 2, causing a frameshift or altered splicing followed by premature termination, is predictable. For example, the level of the altered mRNAs or the corresponding proteins could be severely abated because of an accelerated rate of their degradation resulting from intracellular surveillance (27) . Alternatively, the truncated (14, 18) .
proteins could either be nonfunctional or function sparingly, depending upon the degree of truncation and the concomitant change in conformation. In contrast, functional consequences of the three missense mutations, two in the PH domain (P20 and P14) and one in the kinase domain (P21), are not immediately apparent (Table 1 and Fig. 1 (29) (30) (31) (32) (33) (34) . The binding residues have been mapped in PH domains of pleckstrin, spectrin, dynamin, and Btk (32, 33, 35, 36) . Using a biosensor-based assay, Salim and colleagues (34) (6, 7, 13) . Interestingly, the constitutively acti-vated transforming mutation E41K, produced by in vitro mutagenesis (37) , binds IP4 (and IP5) with the same affinity, and IP6 with a 2-fold higher affinity than the wild type Btk. The fate of the Y40N and Y40C mutations has not been determined yet; however, these alterations are likely to result in a significantly low affinity for IP4 as evidenced by their loss-of-function phenotype in XLA. The fact that both mutations occur at the same residue implies that Y40 is critical for normal function of the PH domain.
Modeling of the 3-D structure of Btk and clustering of XLA-causing mutations suggested the PH domain to have a binding site (18) which, according to the recent X-ray structure, would bind phosphoinositides (32) . Phosphatidylinositol-1,4,5 triphosphate (IP3) has been modeled into the Btk PH domain based on the binding site in PLC-61 (15, 38) . Residues K12, S14, and R28, involved in XLA mutations and residue E41 involved in the gain-of-function mutation, all appear to be involved in PLC-81 type phosphoinositide binding. In the structural model of the PH domain, these residues, along with Y40, cluster on the same plane of the binding site (Fig. 4,  left) . The side chain of Y40 is buried by the loop between ,8-strands 3 and 4, and the hydroxyl group of Y40 could potentially form a hydrogen bond with the backbone of G50 (Fig. 4, left) . Mutations at this site will presumably have structural consequences on the conformation of the loop and the phosphatidylinositol binding site and maybe of the whole domain, and they are likely to be deleterious for the normal function of Btk.
Unlike the PH domains, the kinase domains in both serine/threonine and tyrosine kinases share several conserved hallmark residues (39) . The molecular structure of several kinases from both families has been determined by a variety of means. The three-dimensional scaffolding of these proteins is similar despite very low overall sequence similarities. The kinase domain consists of two lobes. The N-terminal smaller upper lobe comprising mainly the five-stranded antiparallel ,3-sheet is primarily responsible for ATP binding.
The C-terminal larger lower lobe comprising mostly seven a-helices is a major substrate-binding region. The ATP, donating the phosphate group, is bound between the lobes. The regulation of protein kinase activities is a multistep process in which translocation of the upper lobe plays a major role. In the inactive form, the upper part is twisted relative to the lower lobe. In the active form, the ATP and essential Mg2" ions are in their positions between the lobes.
Although XLA-causing kinase domain mutations are scattered along the sequence, they are primarily on one face of the domain, in the side where ATP and substrate are bound (14) . Most of the mutations presumably have structural consequences (13) (14) (15) 38, 40) . The residue 508 is located in a-helix E in the lower lobe of the kinase domain (Fig. 4, right) . Three other mutations involving residues C502, C506, and M509 are also located in this helix (Fig. 4, right; and refs. 9, 16, 25, 38, [41] [42] [43] . Replacement of any of these residues, which are at corresponding positions in successive turns, causes a structural alteration. The mutation A508D introduces a charged residue in the hydrophobic core of the domain and, therefore, is likely to alter its conformation. Polar residues are not allowed to reside in a protein core unless the charge can be neutralized. Another, compensatory mutation would be required to tolerate the A508D mutation.
